Jayshree Jain Acquires 9.86% Stake in Saptak Chem Through Preferential Allotment

Saptak Chem & Business Limited has announced a significant equity acquisition through preferential allotment, with Jayshree Jain emerging as a substantial shareholder. The transaction, disclosed under SEBI's substantial acquisition regulations on April 8, 2026, marks a notable expansion in the company's equity base and investor participation.

Acquisition Details

The acquisition involves Jayshree Jain, who does not belong to the promoter or promoter group, acquiring shares through preferential allotment. The transaction was completed on April 6, 2026, with formal disclosure made under Regulation 29(1) of SEBI (SAST) Regulations, 2011.

Parameter: Details Acquirer: Jayshree Jain Shares Acquired: 5,00,000 Acquisition Mode: Preferential Allotment Transaction Date: April 6, 2026 Promoter Status: Non-promoter entity

Shareholding Impact

The acquisition represents a substantial stake in the company, with Jayshree Jain securing a significant voting position. Prior to this transaction, the acquirer held no shares in the company.

Shareholding Metric: Before Acquisition After Acquisition Shares Held: - 5,00,000 Voting Capital %: - 16.27% Diluted Capital %: - 9.86%

Capital Structure Changes

The preferential allotment has resulted in a substantial expansion of the company's equity base. The transaction involves convertible warrants, with each warrant convertible into one fully paid equity share of ₹10.00 each.

Capital Parameter: Before Transaction After Transaction Equity Share Capital: ₹1,07,32,270 ₹3,07,32,270 Number of Equity Shares: 10,73,227 30,73,227 Total Diluted Share Capital: - 50,73,227

Regulatory Compliance

The disclosure has been made in accordance with Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The company's shares are listed on BSE Limited, ensuring transparency and regulatory oversight of the transaction.

The convertible nature of the securities provides flexibility for future equity conversion, with the warrants carrying specific terms for conversion into fully paid equity shares. This structure allows for potential future expansion of the acquirer's stake based on the conversion timeline and terms specified in the warrant agreement.

Saptak chem & business Limited has filed its quarterly compliance certificate with BSE Limited, fulfilling regulatory requirements under SEBI's depositories regulations for the quarter ended March 31, 2026.

Regulatory Compliance Filing

The company submitted the mandatory certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 on April 8, 2026. Director Jubin Premji Gada signed the submission letter addressed to BSE Limited, confirming the company's adherence to regulatory protocols.

Filing Details: Information Regulation: SEBI (Depositories and Participants) Regulations, 2018 - Section 74(5) Quarter: Q4 FY26 (ended March 31, 2026) Filing Date: April 8, 2026 Signatory: Jubin Premji Gada, Director (DIN: 10820579) Exchange: BSE Limited (Scrip Code: 506906)

Transfer Agent Confirmation

MCS Share Transfer Agent Limited, serving as the company's registrar and transfer agent, provided the required confirmation certificate dated April 7, 2026. The transfer agent confirmed that all securities received from depository participants for dematerialization during Q4 FY26 were properly processed according to regulatory standards.

The confirmation certificate validates that:

Securities received for dematerialization were confirmed to depositories

Security certificates were mutilated and cancelled after due verification

Depository names were substituted in the register of members as registered owners within the mandated 15-day period

All securities remain listed on stock exchanges where previously issued securities are traded

Corporate Information

Saptak Chem and Business Limited operates from its registered office located on the 6th Floor, B-Wing, B D Patel House, Naranpura, Ahmedabad. The company maintains its corporate website at www.saptakchem.com and holds CIN number L24299GJ1980PLC101976.

This quarterly filing demonstrates the company's commitment to maintaining compliance with SEBI's depositories regulations and ensuring proper handling of shareholder securities through authorized transfer agents.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.